SCHEMBL133349

SCHEMBL133349

C=CC(O)COCCCCC

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.53
HTT P42858 2/20 0.52
SPHK1 Q9NYA1 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
LPAR5 Q9H1C0 4/20 0.45
PLA2G2C Q5R387 3/20 0.44
LPAR1 Q92633 7/20 0.41
LPAR3 Q9UBY5 7/20 0.41
LPAR2 Q9HBW0 4/20 0.41
LPAR6 P43657 3/20 0.41
LPAR4 Q99677 3/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9679064 0.98 USP2 (0.56) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL355988 0.94 USP2 (0.46) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL4948086 0.94 USP2 (0.46) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL9187817 0.90 TSHR (0.43) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL3254888 0.80 USP2 (0.53) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL27853729 0.80 USP2 (0.58) USP2HTTSPHK1CYP1A2CYP3A4
Propene SCHEMBL27537993 0.78 HSD17B10 (0.57) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL12276378 0.78 USP2 (0.46) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL415657 0.77 USP2 (0.59) USP2HTTSPHK1CYP1A2CYP3A4
SCHEMBL300014 0.76 USP2 (0.76) USP2HTTSPHK1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228744-A1 POLY(VINYL ALCOHOL) RESIN COMPOSITION AND INJECTION-MOLDED OBJECT MITSUBISHI CHEMICAL CORPORATION (JP) 2024-07-11 US disclosed
CN-118043396-A Resin composition, molded article, multilayer structure, thermoformed container, blow molded container, and vapor deposition film 株式会社可乐丽 2024-05-14 CN disclosed
US-20240100227-A1 IMPLANTATION DEVICE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-03-28 US disclosed
US-11939855-B2 Diverting agent, method for temporarily filling fracture in well using same, and method for further forming fracture MITSUBISHI CHEMICAL CORPORATION (JP) 2024-03-26 US disclosed
US-20240091404-A1 GELATIN-CONTAINING DEVICE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-03-21 US disclosed
US-11898090-B2 Diverting agent and method of filling fracture in well using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2024-02-13 US disclosed
US-11891569-B2 Diverting agent and method of filling fracture in well using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2024-02-06 US disclosed
CN-110997861-B Steering agent and method for plugging cracks in pit using same 三菱化学株式会社 2024-01-12 CN disclosed
EP-4292618-A1 GELATINE-CONTAINING DEVICE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-12-20 EP disclosed
EP-4292619-A1 TRANSPLANTATION DEVICE Shin-Etsu Chemical Co., Ltd. (JP) 2023-12-20 EP disclosed
US-20090023880-A1 POLYVINYL ALCOHOL HAVING 1,2-GLYCOL BOND IN SIDE CHAIN AND PROCESS FOR PREPARING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2009-01-22 US disclosed
EP-2006308-A1 POLYVINYL ACETAL RESIN The Nippon Synthetic Chemical Industry Co., Ltd. (JP) 2008-12-24 EP disclosed
US-20080200633-A1 Polyvinyl alcohol type resin, monolayer film and laminate THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) 2008-08-21 US disclosed
EP-1930352-A1 ACETOACETIC-ESTER-GROUP CONTAINING POLYVINYL ALCOHOL RESIN, RESIN COMPOSITION AND USE THEREOF The Nippon Synthetic Chemical Industry Co., Ltd. (JP) 2008-06-11 EP disclosed
EP-1780227-A1 POLYVINYL ALCOHOL HAVING 1,2-GLYCOL BOND IN SIDE CHAIN AND PROCESS FOR PRODUCING THE SAME The Nippon Synthetic Chemical Industry Co., Ltd. (JP) 2007-05-02 EP disclosed
EP-1169467-A1 PROCESS FOR THE PREPARATION OF PROSTAGLANDIN PRECURSORS Chirotech Technology Limited (GB) 2002-01-09 EP disclosed
US-20010009770-A1 Process for the preparation of prostaglandin precursors FOX MARTIN EDWARD (GB) 2001-07-26 US disclosed
US-6214611-B1 PREPARATION OF A PROPARGYLIC ALCOHOL ENRICHED IN (R)-ENANTIOMER BY ESTERIFICATION OF RACEMIC ALCOHOL USING ACYL DONOR AND ENZYME, REMOVAL OF UNTREATED (S)-ALCOHOL, AND ENANTIOSELECTIVE HYDROLYSIS OF (R)-ESTER USING SECOND ENZYME CHIROTECH TECHNOLOGY LIMITED (GB) 2001-04-10 US disclosed
WO-2000061777-A1 PROCESS FOR THE PREPARATION OF PROSTAGLANDIN PRECURSORS CHIROTECH TECHNOLOGY LIMITED (GB) 2000-10-19 WO disclosed
EP-0042098-A2 Process for the preparation of 1-butene-3,4-diolemonoesters and 1-butene-3-alkyl-3,4-diolemonoesters BASF Aktiengesellschaft (DE) 1981-12-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010009770-A1 Process for the preparation of prostaglandin precursors ADH1A, ADH1C, ADH5 USP2 1620/4885HTT 4828/4885SPHK1 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.